About Us:
We are building an interdisciplinary group of researchers comprised of engineers, chemists, and biologists, all of whom are interested in building things and solving important problems. A commonality within our work is using supramolecular principles to develop creative solutions for issues that arise in healthcare, specifically toward the generation of improved therapeutics. As such, we build platforms based on predictable, tunable, modular, and high-affinity supramolecular interactions that offer unrivaled control over emergent properties. This affords problem-specific tailoring of materials, devices, or constructs to address the task at hand with enabling technologies. The interdisciplinary nature of this work necessitates a highly collaborative culture, and we actively seek partners from throughout the University of Notre Dame as well as the regional and global academic community. In addition, we are always open to partnering with industry leaders in order to help advance our ideas to market.
Recent Tweets:
-
Great day visiting @novonordisk in Indianapolis to discuss the future of insulin and glucagon therapies. Very grate… https://t.co/COP7C79kgS -
RT @withasideofpod: Researchers in the @WebberLab have developed drug-targeting molecules that have the potential to improve how we tre… https://t.co/mMh0VErk0p
-
RT @ACSCentSci: "Researchers have made a hydrogel that, when injected near tumors in mice, recruits drugs to shrink the tumor with… https://t.co/jFrCpBVZif
-
RT @NotreDame: New @UNDResearch has developed small drug-targeting molecules that may be hundreds to thousands of times more effec… https://t.co/y1THo8ZLk0
-
RT @ACSCentSci: Read #ASAP on an alternative drug targeting paradigm using pendant guest motifs to direct molecules to sites distin… https://t.co/EjZ9dsnU5B